NCT06840327 Impact of VARIation of OXYdo-reduction Potential in Cardiac Surgery on Post-operative Outcome
| NCT ID | NCT06840327 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Cardiac Surgery |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-10-07 |
| Primary Completion | 2027-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2025-10-07 with a primary completion date of 2027-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Observational, prospective, monocentric study conducted in the cardiac surgery department about biological markers to predict the short-term outcome of heart surgery patients.
Eligibility Criteria
Inclusion Criteria: Patients over 18 years of age Scheduled cardiac surgery patients undergoing bypass surgery with saphenous vein harvesting. Patients able to understand the protocol; Patients able to express non-opposition to participating in the study Patients affiliated to a social security system or equivalent. Exclusion Criteria: Emergency surgery patients. Pregnant or breast-feeding women. Patients deprived of their freedom or under legal protective measures.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06840327 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06840327 currently recruiting?
Yes, NCT06840327 is actively recruiting participants. Contact the research team at labaste.f@chu-toulouse.fr for enrollment information.
Where is the NCT06840327 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT06840327 clinical trial?
NCT06840327 is sponsored by University Hospital, Toulouse. The trial plans to enroll 120 participants.